Clinical Trials in Hiragi, Kagawa-ken
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Merus B.V.700 enrolled202 locationsNCT06525220
Recruiting
Phase 4
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
ANCA Associated Vasculitis (AAV)
Chiba University160 enrolled22 locationsNCT06611696